TAIRX, INC.
- Country
- πΉπΌTaiwan
- Ownership
- Public
- Established
- 2011-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.trx.com.tw
Study of TRX-920 for Patients With Advanced Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2023-11-22
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- TaiRx, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06143774
- Locations
- π¨π³
National Cheng-Kung University Hospital, Tainan, Taiwan
π¨π³China Medical University Hospital, Taichung, Taiwan
π¨π³Taipei Medical University Hospital, Taipei, Taiwan
CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2022-02-25
- Last Posted Date
- 2023-12-05
- Lead Sponsor
- TaiRx, Inc.
- Target Recruit Count
- 95
- Registration Number
- NCT05257590
- Locations
- π¨π³
National Taiwan University Hospital, Taipei, Taiwan
π¨π³Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan
π¨π³National Cheng Kung University Hospital, Tainan, Taiwan
Safety and Pharmacokinetic Study of CVM-1118 Extended-Release in Advanced Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2020-04-07
- Last Posted Date
- 2022-11-28
- Lead Sponsor
- TaiRx, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT04336124
- Locations
- π¨π³
National Cheng Kung University Hospital, Tainan, Taiwan
π¨π³China Medical University Hospital, Taichung, Taiwan
Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors
- Conditions
- Interventions
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2024-11-26
- Lead Sponsor
- TaiRx, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT03600233
- Locations
- π¨π³
New Taipei Municipal TuCheng Hospital, New Taipei City, Taiwan
π¨π³Chang Gung Memorial Hospital, LinKou, Taoyuan City, Taiwan
π¨π³Chang Gung Memorial Hospital, KaoHsiung, Kaohsiung, Taiwan
CVM-1118 and Sorafenib Combination in Subjects With Advanced Hepatocellular Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2018-07-11
- Last Posted Date
- 2023-01-10
- Lead Sponsor
- TaiRx, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT03582618
- Locations
- π¨π³
National Taiwan University Hospital, Taipei, Taiwan
π¨π³National Cheng Kung University Hospital, Tainan, Taiwan
πΊπΈCharleston Hematology Oncology Associates, Charleston, South Carolina, United States
Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients
- First Posted Date
- 2016-03-09
- Last Posted Date
- 2019-03-28
- Lead Sponsor
- TaiRx, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT02703298
- Locations
- π¨π³
National Cheng Kung University Hospital, Tainan City, Tainan, Taiwan
A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer
- First Posted Date
- 2015-07-24
- Last Posted Date
- 2020-05-21
- Lead Sponsor
- TaiRx, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT02507544
- Locations
- πΊπΈ
South Texas Accelerated Research Therapeutics, LLC (START), San Antonio, Texas, United States
πΊπΈSTART Midwest, Grand Rapids, Michigan, United States